Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy: 12-Month Results from the Phase 3 APPEAR-C3G Study — Carla Nester (2024) | RDL Network
Carla Nester, Richard Smith, David Kavanagh, Marina Vivarelli, Giuseppe Remuzzi, Ming‐Hui Zhao, Edwin Wong, Yaqin Wang, Angelo J. Trapani, Ipsita Krishnan, Nicholas J.A. Webb, Matthias Meier, Andrew S. Bomback
C. Nester, Richard J.H. Smith, David Kavanagh, Marina Vivarelli, Giuseppe Remuzzi, Ming-hui Zhao, Edwin K.S. Wong, Y. Wang, Rubeen Israni, Hari Kalluri, Ipsita Krishnan, Jean Grisouard, Andrew S. Bomback
Edwin Wong, Carla Nester, Teresa Cavero, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Ute Eisenberger, María José Soler, David Kavanagh, Erica Daina, Manuel Praga, Nicholas Medjeral‐Thomas, Anja Gäckler, Clara García-Carro, Andrea Biondani, Frédérique Chaperon, Kenneth Kulmatycki, Julie Milojevic, Nicholas J.A. Webb, Prasanna Kumar Nidamarthy, G. Junge, Giuseppe Remuzzi
C. Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, María Soler, Junhao Liu, Rubeen Israni, Jean Grisouard, Ipsita Krishnan, Edwin Wong
Carla Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, María José Soler Romeo, Junhao Liu, Matthias Meier, Nicholas J.A. Webb, Edwin Wong
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.